The effectiveness of optical imaging processes can be significantly improved with suitable dyes used as contrast agents. Now, researchers have introduced a novel contrast agent that marks tumor cells in vitro. The dye is a phosphorescent ruthenium complex incorporated into nanoparticles of a metal-organic coordination polymer, which allows an extraordinarily high level of dye loading.